Cargando…
Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis
Objective: This study was conducted to elucidate the long non-coding RNA FOXD2-AS1 (lncRNA FOXD2-AS1) expression in glioma and its mechanism on the biological features of glioma cells and the drug resistance of temozolomide (TMZ). Results: Highly expressed FOXD2-AS1 was found in glioma. There was mo...
Autores principales: | Gu, Naibing, Wang, Xinlai, Di, Zhengli, Xiong, Jing, Ma, Yue, Yan, Yu’e, Qian, Yihua, Zhang, Quanzeng, Yu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914387/ https://www.ncbi.nlm.nih.gov/pubmed/31770107 http://dx.doi.org/10.18632/aging.102455 |
Ejemplares similares
-
Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells
por: Nong, Qiaohong, et al.
Publicado: (2021) -
Retracted: Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases
por: Yao, Qinfan, et al.
Publicado: (2022) -
lncRNA ROR Promotes Gastric Cancer Drug Resistance
por: Wang, Shuai, et al.
Publicado: (2020) -
LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma
por: Gao, Yuan‐Feng, et al.
Publicado: (2019)